Fuchs, W <br/><br/>
Lansoprazole does not affect the bioavailability of oral contraceptives.  [electronic resource] 

 -  British journal of clinical pharmacology  Oct 1994 
 - 376-80 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0306-5251 
<br/><br/><label>Standard No.: </label>10.1111/j.1365-2125.1994.tb04370.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>2-Pyridinylmethylsulfinylbenzimidazoles<br/>Adult<br/>Biological Availability<br/>Chromatography, High Pressure Liquid<br/>Contraceptives, Oral--blood<br/>Cross-Over Studies<br/>Estradiol--blood<br/>Ethinyl Estradiol--blood<br/>Female<br/>Follicle Stimulating Hormone--blood<br/>Glucaric Acid--urine<br/>Humans<br/>Hydrocortisone--analogs & derivatives<br/>Lansoprazole<br/>Levonorgestrel--blood<br/>Luteinizing Hormone--blood<br/>Menstrual Cycle<br/>Omeprazole--administration & dosage<br/>Progesterone--blood<br/>Proton Pump Inhibitors<br/>Sex Hormone-Binding Globulin--metabolism<br/>Therapeutic Equivalency